Study of relugolix for heavy periods from uterine fibroids
Treatments studied
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial tests if relugolix can reduce heavy menstrual bleeding caused by uterine fibroids. It may be an option for women who want to avoid surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 or older who has not gone through menopause.
- You have been diagnosed with uterine fibroids and have heavy monthly bleeding because of them.
- You are not planning to have surgery to remove your uterus or ovaries during the study.
- You have not tried and failed treatment with similar hormone-blocking drugs for fibroids before.
- You do not have osteoporosis or other bone disease.
- You do not have a hormonal IUD or implant, or you can have it removed at least 1 month before starting.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how well a long-term treatment using a relugolix combination tablet helps protect bone density in women who have uterine fibroids or endometriosis. It may help people who are at risk of bone thinning while receiving hormone-related symptom treatment.
This trial tests a new medicine called KLH-2109 for women who have uterine fibroids that cause heavy menstrual bleeding. The goal is to see if the medicine can reduce bleeding and improve symptoms.
This trial studies how a progestin hormone—given as an IUD or tablets—can help reduce heavy menstrual bleeding in people with certain bleeding-related conditions. It may help you by testing whether the treatment works and is practical for your situation.
This trial tests two supplements (Elix Cycle Balance and Elix Daily Harmony) to see if they can reduce pain and other symptoms caused by uterine fibroids. It is for women who have regular but painful periods and want to try a non-medicine option.
This trial tests a new device designed to safely remove uterine fibroids (benign growths in the uterus) during minimally invasive laparoscopic surgery while preserving your uterus. The goal is to see if this device makes the procedure faster and safer for women who want to keep their uterus.
This trial tests a capsule called CMS-D002 for heavy periods caused by uterine fibroids. It might help reduce your bleeding if you have fibroids at least 2 cm in size, regular cycles, and are between 18 and 50.
Hear when a new Heavy Menstrual Bleeding trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.